1043 THERAPY RESPONSE IN CHRONIC HEPATITIS C PATIENTS IS AFFECTED BY COMMON VITAMIN D RECEPTOR (NR 1I1) POLYMORPHISMS
Katharina Baur(University Hospital Zurich), Andreas Geier(Swiss Integrative Center for Human Health), Bruno Stieger(University Hospital of Zurich), P. C. Frei, Johannes Schmitt(Universitätsklinikum Würzburg), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), J. S. Braun(University of Zurich), Rika Iwata(University Hospital Zurich), Beat Müllhaupt(University Hospital of Zurich)
Cited by 1
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k